Suchergebnisse - "Weis, Nina"

PubPharm (209)

81

Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe

enthalten in: BMC infectious diseases | 2018

von Colagrossi, L. | Hermans, L. | Salpini, R. | +36

82

Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe

enthalten in: BMC infectious diseases | 2018

von Colagrossi, L. | Hermans, L. | Salpini, R. | +36

83

Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD) : 48-week results of a randomised, double-blind, phase 3, non-inferiority trial

enthalten in: The lancet. HIV | 2018

von Molina, J. | Squires, K. | Sax, P. | +113

CommentIn: Lancet HIV. 2018 May;5(5):e200-e201. - PMID 29592841

84

Anti-müllerian hormone levels are reduced in women living with human immunodeficiency virus compared to control women : a case-control study from Copenhagen, Denmark

enthalten in: Journal of virus eradication | 2018

von Wessman, M. | Korsholm, A. | Bentzen, J. | +4

85

Determination of anti-HCV and quantification of HCV-RNA and IP-10 from dried blood spots sent by regular mail

enthalten in: PloS one | 2018

von Neesgaard, B. | Ruhwald, M. | Krarup, H. | +1

86

Policy responses to hepatitis C in the Nordic countries : Gaps and discrepant reporting in the Hep-Nordic study

enthalten in: PloS one | 2018

von Safreed-Harmon, K. | Hetherington, K. | Aleman, S. | +7

87

Late Presentation for Care Among Patients With Chronic Hepatitis C : Prevalence and Risk Factors

enthalten in: Open forum infectious diseases | 2018

von Hansen, J. | Hallager, S. | Øvrehus, A. | +3

88

Analytical and clinical performance of the Hologic Aptima HCV Quant Dx Assay for the quantification of HCV RNA in plasma samples

enthalten in: Journal of virological methods | 2017

von Schønning, K. | Pedersen, M. | Johansen, K. | +4

89

The significance of HIV to bone mineral density

enthalten in: Ugeskrift for laeger | 2017

von Wessman, M. | Weis, N. | Katzenstein, T. | +4

90

Methodological considerations when calculating person-time at risk for patients with chronic hepatitis C undergoing antiviral treatment

enthalten in: Journal of hepatology | 2017

von Hallager, S. | Ladelund, S. | Weis, N.

CommentOn: J Hepatol. 2016 Jun;64(6):1217-23. - PMID 27059129